{"id":888425,"date":"2025-09-22T14:07:56","date_gmt":"2025-09-22T18:07:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/"},"modified":"2025-09-22T14:07:56","modified_gmt":"2025-09-22T18:07:56","slug":"investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/","title":{"rendered":"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Sept.  22, 2025  (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Jasper Therapeutics, Inc. (\u201cJasper\u201d or the \u201cCompany\u201d) (NASDAQ: JSPR). The lawsuit alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material adverse information regarding Jasper\u2019s business, operations, and compliance policies, including allegations that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company\u2019s products, including briquilimab; (iii) the foregoing increased the likelihood of disruptive cost-reduction measures; and (iv) accordingly, Jasper\u2019s business and\/or financial prospects, as well as briquilimab\u2019s clinical and\/or commercial prospects, were overstated.<\/p>\n<p align=\"justify\">If you purchased shares of Jasper between <strong>November 30, 2023 and July 3, 2025,\u00a0<\/strong>and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A7syjJ0IT05sd39NeioB9Ity_0PT30I6Q8kqtE2oyWq84a7I0GhYb3S0XGaFvpm9khUR4Pe6U0soWstlJezghKc3V1MiHQX_-nKmdkyqWMw=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PZCJeX1QYM5dp76oHiEQzpGaH-M36GU8XZyM997JFE1swdkrfPrd4iAT5PjyThXVLjZ7j4KF5td39CitcbTbHqTWF1IX1-TX3v0EGwP3ybjfzS0i6r0VSryq3TjwMixCz7X8D7KpEYo5fjNgQOd2r7xlVPbEqPPDof0Ft7MUCCA=\" rel=\"nofollow\" target=\"_blank\"><u>www.holzerlaw.com\/case\/jasper-therapeutics\/<\/u><\/a> for more information.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is November 18, 2025.<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PZCJeX1QYM5dp76oHiEQzuPKYQ7W3bCHdjHvfXnWz2C_6NPwG5hxYU5Kmls93aAsHKn59fVbbwiAc_NuQcwEUQpb-sEAChLRsm9TeDDyvTw=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A7syjJ0IT05sd39NeioB9Ity_0PT30I6Q8kqtE2oyWopxiYdLmuQ50skR-ST1t_hqXXV-ZGNFnkL3y-SITC0fcWYv2a0VfckXe36q9CnQew=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjdjMTlhYWUtOGM4OC00OTQwLTg1MjktYWZlMzE5NjUwOTJiLTExOTIzMzYtMjAyNS0wOS0yMi1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Jasper Therapeutics, Inc. (\u201cJasper\u201d or the \u201cCompany\u201d) (NASDAQ: JSPR). The lawsuit alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material adverse information regarding Jasper\u2019s business, operations, and compliance policies, including allegations that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company\u2019s products, including briquilimab; (iii) the foregoing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-888425","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Jasper Therapeutics, Inc. (\u201cJasper\u201d or the \u201cCompany\u201d) (NASDAQ: JSPR). The lawsuit alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material adverse information regarding Jasper\u2019s business, operations, and compliance policies, including allegations that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company\u2019s products, including briquilimab; (iii) the foregoing &hellip; Continue reading &quot;INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-22T18:07:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0\",\"datePublished\":\"2025-09-22T18:07:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/\",\"name\":\"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=\",\"datePublished\":\"2025-09-22T18:07:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0 - Market Newsdesk","og_description":"ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Jasper Therapeutics, Inc. (\u201cJasper\u201d or the \u201cCompany\u201d) (NASDAQ: JSPR). The lawsuit alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material adverse information regarding Jasper\u2019s business, operations, and compliance policies, including allegations that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company\u2019s products, including briquilimab; (iii) the foregoing &hellip; Continue reading \"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-22T18:07:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0","datePublished":"2025-09-22T18:07:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/","name":"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=","datePublished":"2025-09-22T18:07:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMzA3MyM3MTU4NTI0IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-class-action-lawsuit-filed-on-behalf-of-jasper-therapeutics-inc-jspr-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=888425"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888425\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=888425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=888425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=888425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}